Evogene
EVGN • NASDAQ
Evogene is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ofer Haviv, with a market cap of $8.1M.
Market Cap$8.1M
Employees143.0
CEOOfer Haviv
CountryIsrael
Healthcare
Biotechnology
Next EarningsMay 20, 2026 · in a monthQ1 2026
Financials
Evogene FAQ
Common questions about Evogene
Evogene is scheduled to report earnings for Q1 2026 on May 20, 2026. Analysts estimate revenue of $350.0K.
Evogene has approximately 143 employees.